PATENT CLAIM ANALYSIS

Application Number: 16060057
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "640000"]

Abstract:
Disclosed is a malononitrile oxime ether compound having a novel structure as shown in the general formula I. Respective substituents in the general formula I as defined in the specification. The compound of the general formula I exhibits an excellent microbicidal activity, and can effectively prevent and treat plant diseases caused by bacteria and fungi. Also provided is a use of the compound of the general formula I as a microbicide in the agricultural and other fields.

Claim (Index 2):
The compound according to the  claim 1 , characterized in that wherein general formula I:\n L represents a divalent group selected in the list consisting of\n \u2014(CR 1 R 2 ) n \u2014 \u2014(CR 1 R 2 ) m \u2014CH 2 \u2014(C\u2550O)\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014 \n \u2014(CR 1 R 2 ) m \u2014(CR 1 \u2550CR 2 )\u2014(CR 1 R 2 ) p \u2014 \u2014(CR 1 R 2 ) m \u2014(C\u2550O)\u2014O\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014 \n \u2014(CR 1 R 2 ) m \u2014(C\u2261C)\u2014(CR 1 R 2 ) p \u2014 \u2014(CR 1 R 2 ) m \u2014O\u2014(C\u2550O)\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014 \n \u2014(CR 1 R 2 ) m \u2014O\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014 \u2014(CR 1 R 2 ) m \u2014(C\u2550O)\u2014NH\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014 \n \u2014(CR 1 R 2 ) m \u2014NH\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014 \u2014(CR 1 R 2 ) m \u2014NH\u2014(C\u2550O)\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014, \n \u2014(CR 1 R 2 ) m \u2014S\u2014CH 2 \u2014(CR 1 R 2 ) p \u2014; \n n represents 1, 2, 3 or 4; m and p independently represent 0, 1, 2 or 3; R 1  and R 2  are selected from hydrogen; W is selected in the list consisting of W 1  to W 84 : Wherein X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 , X 8  and X 9  are independently selected in the list consisting of hydrogen, halogen, cyano, nitro, \u2014SF 5 , [C 1 -C 8 ]-alkyl, [C 1 -C 8 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 2 -C 8 ]-alkenyl, [C 2 -C 8 ]-haloalkenyl, [C 2 -C 8 ]-alkynyl, [C 2 -C 8 ]-haloalkynyl, [C 1 -C 8 ]-alkoxy-[C 1 -C 8 ]-alkyl, \u2014OR 3 , \u2014C(\u2550O)OR 3 , \u2014N(R 4 )S(\u2550O) 2 R 5 , \u2014S(\u2550O) 2 NR 3 R 5 , \u2014N(R 4 )C(\u2550O)OR 3 , \u2014CR 4 \u2550NOR 3 , \u2014CH 2 ON\u2550C(CN) 2 , \u2014C(\u2550O)SR 3 , \u2014C(\u2550S)OR 3 , \u2014C(\u2550S)SR 3 , \u2014CR 4 \u2550NR 5 , \u2014CR 4 \u2550N\u2014NR 3 R 5 , \u2014OSiR 4 R 5 R 6 , \u2014OC(\u2550O)R 4 , \u2014OC(\u2550O)OR 3 , \u2014OC(\u2550O)NR 3 R 4 , \u2014OC(\u2550S)NR 3 R 4 , \u2014NR 3 R 4 , \u2014N(R 4 )C(\u2550O)NR 3 R 5 , \u2014N(R 4 )C(\u2550S)NR 3 R 5 , \u2014N\u2550CR 4 R 5 , \u2014N\u2550C\u2014NR 3 R 4 , \u2014N(R 4 )C(\u2550NR 5 )NR 3 R 6 , \u2014N(R 4 )OR 3 , \u2014N(R 4 )NR 3 R 5 , \u2014N\u2550NR 4 , \u2014N(R 4 )S(\u2550O)R 5 , \u2014N(R 4 )S(\u2550O) 2  OR 3 , \u2014N(R 4 )S(\u2550O)OR 3 , \u2014N(R 4 )S(\u2550O)NR 3 R 5 , \u2014N(R 4 )S(\u2550O) 2 NR 3 R 5 , NR 4 C(\u2550O)R 5 , \u2014SR 3 , \u2014S(\u2550O) 2  R 4 , \u2014S(\u2550O)R 4 , \u2014S(\u2550O)OR 3 , \u2014S(\u2550O)NR 3  R 4 , \u2014S(\u2550O) 2  OR 3 , \u2014S(\u2550O)NR 3  R 4 , \u2014Si R 3 R 4 R 5 , non-substituted or substituted phenyl, non-substituted or substituted pyridyl, non-substituted or substituted pyrazolyl, non-substituted or substituted thiazolyl, non-substituted or substituted isothiazolyl and non-substituted or substituted thiadiazolyl, wherein substituent group is selected in the list consisting of halogen, cyano, nitro, [C 1 -C 8 ]-alkyl, [C 1 -C 8 ]-haloalkyl, [C 1 -C 8 ]-alkoxy, [C 1 -C 8 ]-haloalkoxy, [C 1 -C 8 ]-alkylthio or [C 1 -C 8 ]-haloalkylthio; Z is selected in the list consisting of hydrogen, [C 1 -C 8 ]-alkyl, [C 1 -C 8 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 2 -C 8 ]-alkenyl, [C 2 -C 8 ]-haloalkenyl, [C 2 -C 8 ]-alkynyl, [C 2 -C 8 ]-haloalkynyl, aryl, aryl-[C 1 -C 8 ]-alkyl, [C 1 -C 8 ]-alkoxy-[C 1 -C 8 ]-alkyl, \u2014C(\u2550O) R 3  and \u2014C(\u2550O)OR 3 ; K is selected in the list consisting of oxygen, sulfur, NR 3 , N\u2014OR 4  and N\u2014NR 3 R 4 ; R 3  is selected in the list consisting of hydrogen, [C 1 -C 8 ]-alkyl, [C 1 -C 8 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 1 -C 8 ]-alkoxycarbonyl, [C 2 -C 8 ]-alkenyl, [C 2 -C 8 ]-haloalkenyl, [C 2 -C 8 ]-alkynyl, [C 2 -C 8 ]-haloalkynyl, non-substituted or substituted phenyl, non-substituted or substituted pyridyl, non-substituted or substituted pyrazolyl, non-substituted or substituted thiazolyl, non-substituted or substituted isothiazolyl and non-substituted or substituted thiadiazolyl, wherein substituent group is selected in the list consisting of halogen, cyano, nitro, hydroxyl, mercapto, amino, CONH 2 , COOH, CHO, [C 1 -C 4 ]-alkyl, [C 1 -C 4 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 1 -C 3 ]-alkoxy, [C 1 -C 3 ]-haloalkoxy, [C 1 -C 3 ]-alkylthio, [C 1 -C 3 ]-haloalkylthio, [C 1 -C 3 ]-alkylamino, [C 1 -C 3 ]-dialkylamino, [C 3 -C 6 ]-cycloalkylamino, [C 1 -C 3 ]-alkoxycarbonyl, [C 1 -C 3 ]-alkylsulfonyl, [C 1 -C 3 ]-alkylaminocarbonyl and [C 1 -C 3 ]-alkylaminosulfonyl; R 4 , R 5  and R 6  are independently selected in the list consisting of hydrogen, [C 1 -C 8 ]-alkyl, [C 1 -C 8 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 1 -C 8 ]-alkoxy, [C 1 -C 8 ]-haloalkoxy, [C 1 -C 8 ]-alkoxycarbonyl, [C 2 -C 8 ]-alkenyl, [C 2 -C 8 ]-haloalkenyl, [C 2 -C 8 ]-alkynyl, [C 2 -C 8 ]-haloalkynyl, non-substituted or substituted phenyl, non-substituted or substituted pyridyl, non-substituted or substituted pyrazolyl, non-substituted or substituted thiazolyl, non-substituted or substituted isothiazolyl and non-substituted or substituted thiadiazolyl, wherein substituent group is selected in the list consisting of halogen, cyano, nitro, hydroxyl, mercapto, amino, CONH 2 , COOH, CHO, [C 1 -C 4 ]-alkyl, [C 1 -C 4 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 1 -C 3 ]-alkoxy, [C 1 -C 3 ]-haloalkoxy, [C 1 -C 3 ]-alkylthio, [C 1 -C 3 ]-haloalkylthio, [C 1 -C 3 ]-alkylamino, [C 1 -C 3 ]-dialkylamino, [C 3 -C 6 ]-cycloalkylamino, [C 1 -C 3 ]-alkoxycarbonyl, [C 1 -C 3 ]-alkylsulfonyl, [C 1 -C 3 ]-alkylaminocarbonyl and [C 1 -C 3 ]-alkylaminosulfonyl; Q is selected in the list consisting of non-substituted or substituted phenyl, non-substituted or substituted pyridyl, non-substituted or substituted pyrazolyl, non-substituted or substituted thiazolyl, non-substituted or substituted isothiazolyl and non-substituted or substituted thiadiazolyl, wherein substituent group is selected in the list consisting of halogen, cyano, nitro, hydroxyl, mercapto, amino, CONH 2 , COOH, CHO, [C 1 -C 4 ]-alkyl, [C 1 -C 4 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 1 -C 3 ]-alkoxy, [C 1 -C 3 ]-haloalkoxy, [C 1 -C 3 ]-alkylthio, [C 1 -C 3 ]-haloalkylthio, [C 1 -C 3 ]-alkylamino, [C 1 -C 3 ]-dialkylamino, [C 3 -C 6 ]-cycloalkylamino, [C 1 -C 3 ]-alkoxycarbonyl, [C 1 -C 3 ]-alkylsulfonyl, [C 1 -C 3 ]-alkylaminocarbonyl and [C 1 -C 3 ]-alkylaminosulfonyl; T is selected in the list consisting of cyano, [C 1 -C 8 ]-alkyl, [C 1 -C 8 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 2 -C 8 ]-alkenyl, [C 2 -C 8 ]-haloalkenyl, [C 2 -C 8 ]-alkynyl, [C 2 -C 8 ]-haloalkynyl, non-substituted or substituted phenyl, non-substituted or substituted pyridyl, non-substituted or substituted pyrazolyl, non-substituted or substituted thiazolyl, non-substituted or substituted isothiazolyl and non-substituted or substituted thiadiazolyl, wherein substituent group is selected in the list consisting of halogen, cyano, nitro, hydroxyl, mercapto, amino, CONH 2 , COOH, CHO, [C 1 -C 4 ]-alkyl, [C 1 -C 4 ]-haloalkyl, [C 3 -C 6 ]-cycloalkyl, [C 1 -C 3 ]-alkoxy, [C 1 -C 3 ]-haloalkoxy, [C 1 -C 3 ]-alkylthio, [C 1 -C 3 ]-haloalkylthio, [C 1 -C 3 ]-alkylamino, [C 1 -C 3 ]-dialkylamino, [C 3 -C 6 ]-cycloalkylamino, [C 1 -C 3 ]-alkoxycarbonyl, [C 1 -C 3 ]-alkylsulfonyl, [C 1 -C 3 ]-alkylaminocarbonyl and [C 1 -C 3 ]-alkylaminosulfonyl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.65306
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10030189', '14421556', '10044183', '12668939', '16328128']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8221899901815082
- 35 USC 102 Novelty (BERT): 0.5190052444516778
- Combined Prediction Score: 0.7918715156085252
- Mean Citation Score: 298.4080780000001
- Max Citation Score: 302.70947
- Similarity Product: 200.2451221674371

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test